Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Phase 1 Cancer Trials

Aurora, Colorado

Phase 1 cancer trials in Aurora, CO

56 Phase 1 cancer studies are recruiting participants at sites in Aurora as of November 17, 2026, according to ClinicalTrials.gov. Phase 1 Cancer Trials can help you understand your options and connect with a study team.

Call (888) 927-9038
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Aurora at a glance

Breast cancer studies recruiting in Aurora

Basic details from each study's public record (the 30 most recently updated of 56). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Phase 1/2 Study of IAM1363 in HER2 Cancers

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Iambic Therapeutics, Inc
    Study site
    University of Colorado Cancer Center
    Registry record
    NCT06253871 · updated
  2. Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Study site
    University of Colorado Anschutz Medical Campus ( Site 0057)
    Registry record
    NCT06686394 · updated
  3. A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Mabwell (Shanghai) Bioscience Co., Ltd.
    Study site
    Anschutz Medical Center
    Registry record
    NCT06908928 · updated
  4. A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Genentech, Inc.
    Study site
    University of Colorado Cancer Center
    Registry record
    NCT07100106 · updated
  5. First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Accent Therapeutics
    Study site
    University of Colorado Denver
    Registry record
    NCT06799065 · updated
  6. Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Olema Oncology, Inc.
    Study site
    University of Colorado
    Registry record
    NCT06784193 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Aurora, CO on ClinicalTrials.gov.

Lung cancer studies recruiting in Aurora

  1. A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 to 99
    • All sexes
    Sponsor
    Erasca, Inc.
    Study site
    University of Colorado
    Registry record
    NCT06983743 · updated
  2. Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    SystImmune Inc.
    Study site
    University of Colorado - Anschutz Cancer Pavilion
    Registry record
    NCT07080242 · updated
  3. A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Study site
    University of Colorado, Anschutz Cancer Pavilion ( Site 0125)
    Registry record
    NCT07227597 · updated
  4. A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    TRIANA Biomedicines, Inc.
    Study site
    University of Colorado Cancer Center
    Registry record
    NCT07491497 · updated
  5. Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    AbbVie
    Study site
    University Of Colorado - Anschutz Medical Campus /ID# 269069
    Registry record
    NCT06772623 · updated
  6. Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Pfizer
    Study site
    Rocky Mountain Cancer Centers,LLP
    Registry record
    NCT07227298 · updated
  7. A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Study site
    University of Colorado Anschutz Medical Campus ( Site 1110)
    Registry record
    NCT06780137 · updated
  8. Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

    • Phase 1/2
    • Ages 18 to 130
    • All sexes
    Sponsor
    AstraZeneca
    Registry record
    NCT05797168 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Aurora, CO on ClinicalTrials.gov.

Prostate cancer studies recruiting in Aurora

  1. A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer

    • Phase 1
    • Ages 18 and older
    • Male participants
    Sponsor
    Janssen Research & Development, LLC
    Study site
    University of Colorado Anschutz Medical Campus
    Registry record
    NCT06095089 · updated
  2. FOG-001 in Locally Advanced or Metastatic Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Parabilis Medicines, Inc.
    Study site
    University of Colorado
    Registry record
    NCT05919264 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Aurora, CO on ClinicalTrials.gov.

Melanoma studies recruiting in Aurora

  1. A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

    • Phase 1/2
    • From 6 months, up to 17 years
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Study site
    Call for Information (Investigational Site 0019)
    Registry record
    NCT02332668 · updated
  2. A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Relay Therapeutics, Inc.
    Study site
    University of Colorado Hospital
    Registry record
    NCT07584226 · updated

Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Aurora, CO on ClinicalTrials.gov.

Lymphoma studies recruiting in Aurora

  1. The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

    • Phase 1/2
    • Up to age 22
    • All sexes
    Sponsor
    PedAL BCU, LLC
    Study site
    Children's Hospital Colorado
    Registry record
    NCT04726241 · updated
  2. Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Nurix Therapeutics, Inc.
    Study site
    Rocky Mountain Cancer Centers
    Registry record
    NCT07520006 · updated
  3. A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)

    • Phase 1
    • Ages 0 to 18
    • All sexes
    Sponsor
    Autolus Limited
    Study site
    Children's Hospital Colorado
    Registry record
    NCT06173518 · updated
  4. A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

    • Phase 1/2
    • Ages 12 and older
    • All sexes
    Sponsor
    Nuvalent Inc.
    Study site
    University of Colorado Cancer Center
    Registry record
    NCT05384626 · updated
  5. A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    University of Colorado Denver - School of Medicine - Anschutz Medical Campus
    Registry record
    NCT07101328 · updated
  6. Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

    • Phase 1/2
    • From 6 months, up to 25 years
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Study site
    Children's Hospital Colorado-Center for Cancer and Blood Disorders ( Site 1016)
    Registry record
    NCT06395103 · updated
  7. A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

    • Phase 1/2
    • From 30 days
    • All sexes
    Sponsor
    Syndax Pharmaceuticals
    Study site
    University of Colorado
    Registry record
    NCT04065399 · updated
  8. Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    SciTech Development, Inc.
    Study site
    University of Colorado Anschutz Medical Campus
    Registry record
    NCT04234048 · updated
  9. A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

    • Phase 1/2
    • Up to age 25
    • All sexes
    Sponsor
    Turning Point Therapeutics, Inc.
    Study site
    Children's Hospital Colorado - Anschutz Medical Campus
    Registry record
    NCT04094610 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Aurora, CO on ClinicalTrials.gov.

Pancreatic cancer studies recruiting in Aurora

  1. Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    University of Colorado, Denver
    Study site
    University of Colorado Cancer Center
    Registry record
    NCT07030283 · updated
  2. A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Study sites
    University of Colorado Anschutz Medical Campus ( Site 0299) · University of Colorado Anschutz Medical Campus ( Site 0325) · University of Colorado Anschutz Medical Campus ( Site 0326)
    Registry record
    NCT06428409 · updated
  3. A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    GlaxoSmithKline
    Study site
    GSK Investigational Site
    Registry record
    NCT06885034 · updated

Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Aurora, CO on ClinicalTrials.gov.

Ask about studies near Aurora

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Colorado

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.

Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-9038

or send a short form

How should we reach you?

Call